Access the complete GLP-1 Pipeline Update table for August 2025
Semaglutide is a GLP-1 agonist that works by increasing insulin release, lowering the amount of glucagon released, delaying gastric emptying, and reducing appetite
Trying to figure out childcare arrangements just so you can go to your own appointment
Simultaneously, these agents suppress glucagon secretion from pancreatic alpha cells, particularly during hyperglycemic states
Dr Rhona Cameron (GMC 6103281), Medical Director of Womens Health at McKeown Medical and a University of Glasgow-trained GP, is a skilled injector extensively trained in Dr McKeowns signature intuitive technique
Frequently Asked Questions Questions are useful tools, they open lines of communication